Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 30 November 2017

 
 
 
   

#WeWontRest guest blog

 
A life as normal as possible for people living with Diabetes
A guest blog by Beate Kretschmer, Director Market Access at Lilly Germany

Latest estimates show that over 60 million Europeans live with diabetes. In Germany, this holds true for about 7.5 million people – with a rising tendency. As people are being diagnosed with diabetes at an increasingly younger age, in Germany alone, over 2 million patients with the chronic condition are of working age. This is why we are committed to improve the conditions for people living and working with diabetes. Read more


 
 
 
   

News

 

28112017 Europe’s life science industry urges the UK and EU27 to safeguard patients’ access...
28 November 2017

Even in the context of the Brexit negotiations where all sectors are looking for clarity on the future, it’s important... Read more

29112017 European Commission launches: “What I need to know about Biosimilar Medicines - Information...
29 November 2017

Today the European Commission launched the translations of the Q&A paper: “What I need to know about Biosimilar Medicines... Read more

 
 
 
   

Blogs

 

24112017 Incentives, IP and smaller companies; case story: Transgene
24 November 2017

IP rights and EU pharmaceutical incentives enable innovation for the cures of tomorrow Read more

29112017 EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing...
29 November 2017 - Sini Eskola

Making research data available to qualified researchers has the great potential to advance medical research to benefit... Read more

 
 
 
   

Documents

 

Report on the 2016 Member Company Survey on the EFPIA-PhRMA Principles for Responsible Clinical...
29 November 2017 (Publications)

The biopharmaceutical industry believes that the disclosure of clinical trial results and appropriate sharing of clinical... Read more

 
 
 
   

What we are reading

 
Cancer, neurodegenerative disease and medicines safety feature in new IMI Call for proposals...
On 01 December 2017 (IMI)

Today, the Innovative Medicines Initiative (IMI) is launching a new Call for proposals covering diabetes, antimicrobial... Read more

UK and pharma industry call for transition period for medicines supply
On 29 November 2017 (EurActiv)

With Brexit barely 15 months away, the UK government, as well as the European and British life science industry, is... Read more